about
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideTargeting the androgen receptor in prostate and breast cancer: several new agents in developmentFeeding soy protein isolate and treatment with estradiol have different effects on mammary gland morphology and gene expression in weanling male and female ratsLow salivary testosterone levels in patients with breast cancer.Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancersCirculating sex hormones and terminal duct lobular unit involution of the normal breast.Teenage acne and cancer risk in US women: A prospective cohort studyThe Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activationPostmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase DeficiencyLong-Term Follow-Up of Individuals Undergoing Sex-Reassignment Surgery: Somatic Morbidity and Cause of DeathBioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer.Androgens and breast cancer risk.Androgen receptor antagonists: a patent review (2008-2011).Postmenopausal breast cancer, androgens, and aromatase inhibitors.Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen.Testosterone and risk of breast cancer: appraisal of existing evidence.Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant's Perspective.When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer.Steroid hormone receptors as prognostic markers in breast cancer.5α-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth.Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cells.Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.State of the evidence 2017: an update on the connection between breast cancer and the environmentAge at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.The effect of country wealth on incidence of breast cancer.An age-dependent interaction between sex and geographical UV index in melanoma risk.Post-menopausal breast cancer: from estrogen to androgen receptor.Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.AR Expression in Breast Cancer CTCs Associates with Bone Metastases.Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
P2860
Q21195191-03CC5678-8DCB-4A86-811B-2C89697EBC66Q27009424-F309D90F-FFA1-4E9C-A304-F77A568684E5Q28581258-F6FEE7C5-3535-41A3-9305-AC90F2DDE77CQ33715095-A7C57205-7038-4FB5-AB4B-61D2B383082DQ33728381-0F7E59A8-8AD6-4974-8395-C002E7D8DDD9Q34228066-2EF277FA-991B-46EF-9683-BBE9DB8ABF2CQ34764884-E8CF6F11-F924-40ED-9B24-6AAE7476DBE7Q35098777-6988E397-ABE4-4855-AA94-0E711E9EE857Q35582276-DDC5AA72-B5A4-4400-9004-E91B8569A999Q36087106-B0D79EEA-690D-4D7B-9409-9D93EF5C9838Q36113793-F1FE3CC2-38E0-4C12-A348-BE6A85FF96E1Q36367151-4782999A-35B2-4615-81F2-A0ADE7CC9FABQ36393201-7CEC775E-32DF-47B7-8126-BB370E90E73AQ36638994-D7C7A74C-D423-4614-91B7-BB9E8AA35790Q36722525-B08D7FCF-63BA-4700-AB2D-F13FED6F69CBQ36770055-EE6D87FE-E1D6-4AD8-9999-54953A4D8AD0Q36947561-178D828E-6315-426C-B765-8CFFF7021D8BQ37991007-3DEAB998-2439-4B55-926D-AF9B272829F8Q38009888-AC87B1BA-4006-4202-82F4-984D1C9E6FE6Q38097730-2513A3EA-776B-4FD2-96E8-1BB2B35896EEQ38360282-20CB16E3-E564-47BB-8BEF-27AF03B2A029Q38471436-E225A489-B6DE-4038-A0EA-28289B64D3D2Q38530405-3AE1C2AA-B24F-435A-AAAD-043357A78D9FQ38543908-29E8B8D0-6027-4EDE-BEA1-16F30CC3420DQ38598704-396FE584-5632-445E-BB21-283FBCDED99FQ38845216-4679245C-30F1-44ED-A045-A39316D2B7F8Q39523591-2C543D37-0F0E-47FA-B4CC-A9521C236118Q39734169-918957B0-B3FF-487E-AD9C-AE60EE94EA0FQ41595188-EB7CD4CF-D11A-45D4-A2C9-88BC2EEAA235Q44103718-A499F9D3-8531-4328-96CE-66F5D1A8865EQ44662736-8FF787EE-E54D-4FF8-B9F3-E84810713A1CQ46314406-F6E8A768-74B7-4C35-B31D-E2A969C6AB78Q47094109-33434645-048B-4208-91C8-933A11BB66EEQ48229904-F43F695D-71AD-49EC-AC63-91AEFD9B9F02Q49913672-C7A9B5A0-1F99-4E28-B3D5-EDBF7E10C509Q54481449-5183EBA2-D688-4B9F-A207-0852B976B9CD
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Androgens and the breast.
@en
Androgens and the breast.
@nl
type
label
Androgens and the breast.
@en
Androgens and the breast.
@nl
prefLabel
Androgens and the breast.
@en
Androgens and the breast.
@nl
P2860
P921
P356
P1476
Androgens and the breast.
@en
P2093
Carolyn Bondy
Constantine Dimitrakakis
P2860
P2888
P356
10.1186/BCR2413
P577
2009-01-01T00:00:00Z
P5875
P6179
1025897143